BMO commits $5 million to advance surgical innovation and precision cancer care at UHN's Toronto Western Hospital and Princess Margaret Cancer Centre
MWN-AI** Summary
BMO Financial Group has announced a significant $5 million philanthropic contribution aimed at enhancing surgical innovation and precision cancer care at the University Health Network (UHN). This investment will support the construction of a new Surgical Tower at Toronto Western Hospital and bolster the PMATCH initiative at the Princess Margaret Cancer Centre, an AI-driven platform designed to connect cancer patients with appropriate clinical trials.
Darryl White, BMO's CEO, emphasized the importance of this investment in prioritizing patient-centered care. The Surgical Tower, a pioneering facility, is set to address the growing demand for complex surgical procedures, modernizing operating rooms and significantly expanding surgical capacity. This initiative signifies BMO's commitment to fostering technological innovation and collaboration within the healthcare sector.
Additionally, the funding will facilitate the advancement of PMATCH, which utilizes artificial intelligence to match patients' unique clinical and genomic profiles with suitable clinical trials. Initially launching at the Princess Margaret Cancer Centre, the program is expected to extend to other hospitals across Canada. The goal is to enhance patient screening, streamline trial enrollment, and promote equity in cancer treatment research and care.
Dr. Kevin Smith, UHN's President & CEO, praised BMO's generosity, highlighting its potential to drive innovation and collaboration in healthcare. The shared commitment to patient-centered care through advanced infrastructure and targeted initiatives like PMATCH underscores the transformative power of philanthropy in healthcare.
This milestone reflects BMO's broader efforts to support community development and healthcare excellence, as part of its overarching mission to "Boldly Grow the Good" in business and life. Through this collaboration, BMO and UHN aim to strengthen Canada’s healthcare system, improving access to cutting-edge care and advancing cancer treatment for patients across the region.
MWN-AI** Analysis
BMO Financial Group's recent $5 million investment in University Health Network (UHN) to advance surgical innovation and precision cancer care underscores a strategic move that not only enhances healthcare but also signifies a deliberate approach to community engagement and corporate responsibility. This initiative, particularly the enhancement of the Surgical Tower at Toronto Western Hospital and the AI-powered PMATCH project at Princess Margaret Cancer Centre, positions BMO favorably within the growing healthcare sector.
From a market perspective, this investment highlights several compelling trends. It reflects a shift towards personalized healthcare, driven by technological advancements such as artificial intelligence in oncology. The PMATCH initiative, utilizing AI for better patient-trial matching, can significantly streamline cancer research and trials, potentially leading to breakthroughs that enhance patient outcomes. This aligns with a broader trend toward technology integration in healthcare, presenting a potential growth area for healthcare technology companies.
Furthermore, BMO’s commitment to community-centric projects resonates well with the increasing demand for corporate social responsibility (CSR). Companies that engage meaningfully with community health initiatives often see a positive impact on their brand reputation and customer loyalty, which can translate into financial returns over time. As healthcare systems worldwide adapt to meet increasing patient demands, both in capacity and innovation, BMO's support can enhance its image as a leader in corporate philanthropy, potentially attracting positive investor sentiment.
Investors should closely monitor the outcomes of BMO’s investment, as successful implementation could position the bank as a front-runner in health-focused philanthropy. Additionally, with heightened public awareness and interest in health innovation, similar initiatives could create opportunities for partnerships and collaborative projects within the sector. Keeping an eye on the evolving landscape of healthcare investments, driven by technology and patient-centric solutions, will be crucial for those looking to capitalize on the intersection of finance and health innovation.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Canada NewsWire
TORONTO, March 30, 2026 /CNW/ - University Health Network (UHN) is pleased to announce a $5-million philanthropic gift from BMO to support the construction of a new Surgical Tower at UHN's Toronto Western Hospital and the expansion of PMATCH, an AI-powered precision oncology initiative at UHN's Princess Margaret Cancer Centre.
"We're proud to support UHN as they lead the way in transforming life-changing care for patients with cancer," said Darryl White, CEO of BMO Financial Group and Campaign Cabinet Co-Chair of the UHN Surgical Tower Campaign. "This investment puts the patient first by fostering a culture of technology innovation, collaboration and empowerment, which are key contributors to the high-quality health care that strengthens our communities."
BMO's gift will play a critical role in advancing cancer treatment at both Princess Margaret Cancer Centre and UHN's new Surgical Tower at Toronto Western Hospital, a first-of-its-kind initiative designed to meet the growing and increasingly complex surgical needs of patients across Ontario and beyond. Purpose-built to drive innovation, the Tower will significantly expand surgical capacity, modernize operating rooms and provide an elevated care journey for patients and their loved ones.
BMO's gift will also support PMATCH, a world-first, AI-powered initiative that uses artificial intelligence to better connect cancer patients with the most suitable clinical trials – first at Princess Margaret Cancer Centre, and ultimately expanding to other participating Canadian hospitals. Using individual clinical and genomic profiles, PMATCH will improve patient screening through automation, streamline trial enrollment and support more efficient and equitable cancer research and care.
"This generous gift from BMO reflects the power of philanthropy to drive both innovation and collaboration across our healthcare system," said Dr. Kevin Smith, President & CEO of University Health Network. "Support for the new Surgical Tower will help UHN meet the growing demand for complex surgical care, while this shared investment alongside The Princess Margaret to advance PMATCH will improve how patients are connected to clinical trials and accelerating discovery for patients across Canada."
Together, these investments reflect a shared commitment to advancing patient-centred care through both state-of-the-art infrastructure and targeted innovation. By supporting the Surgical Tower and PMATCH, BMO's gift will help expand access to care, accelerate discovery and strengthen Canada's health care system for patients today and in the future.
More about UHN Foundation
Part of University Health Network (UHN), Canada's #1 hospital and the world's #1 publicly funded hospital, UHN Foundation raises funds for Toronto General Hospital, Toronto Western Hospital, Toronto Rehab and The Michener Institute of Education. No one ever changed the world on their own: Donor support is critical to upholding the excellence in patient care that UHN is known for and changing the status quo of health care – helping to recruit and train the brightest medical minds from around the world, develop new treatments for disease, complete transformational capital projects, and advance bold medical research. UHNfoundation.ca
More about The Princess Margaret Cancer Foundation
The Princess Margaret Cancer Foundation is Canada's largest cancer charity. We're dedicated to raising funds for Princess Margaret Cancer Centre, one of the world's leading cancer research and treatment centres, known for its breakthrough discoveries that transform patient outcomes. Together, our work benefits cancer patients everywhere in our mission to create a world free from the fear of cancer. Through philanthropy, fundraising events, and our world-leading lottery program, we're changing how the world understands, prevents, diagnoses, and treats cancer, benefitting patients at The Princess Margaret, throughout Canada, and around the world. thepmcf.ca
BMO Gives. Good grows here.
Helping communities thrive by supporting the organizations that sustain them and encouraging employee giving and volunteerism is at the heart of BMO's Purpose, to Boldly Grow the Good in business and life.
In 2025, we directed more than $124 million to drive progress for communities, which included $115.7 million in philanthropic contributions to hundreds of charities and nonprofit organizations across North America.
Our colleagues spent over 65,000+ hours volunteering in the community and contributed more than $40.3 million of donations through employee-driven giving in our annual campaigns.
For more information, please visit BMO Gives.
SOURCE BMO Financial Group
View original content: http://www.newswire.ca/en/releases/archive/March2026/30/c6163.html
FAQ**
How does the $5 million commitment from Bank Of Montreal BMO align with the broader strategic goals of UHN's Toronto Western Hospital and Princess Margaret Cancer Centre in enhancing cancer care and surgical innovation?
What specific advancements in surgical capacity and patient care can be expected at the new Surgical Tower funded by Bank Of Montreal BMO’s contribution, and how will these benefit patients across Ontario?
In what ways will the PMATCH initiative, supported by Bank Of Montreal BMO, utilize AI technology to improve patient access to clinical trials, and what impact do you anticipate this will have on cancer research in Canada?
How does Bank Of Montreal BMO's philanthropic investment reflect its overall commitment to community health and wellness, particularly in the context of increasing demands for complex surgical procedures and cancer treatment?
**MWN-AI FAQ is based on asking OpenAI questions about Bank of Montreal (TSXC: BMO:CC).
NASDAQ: BMO:CC
BMO:CC Trading
-0.19% G/L:
$126.18 Last:
6,121,058 Volume:
$126.42 Open:
